» Articles » PMID: 20007804

Ras-induced Reactive Oxygen Species Promote Growth Factor-independent Proliferation in Human CD34+ Hematopoietic Progenitor Cells

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2009 Dec 17
PMID 20007804
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Excessive production of reactive oxygen species (ROS) is a feature of human malignancy and is often triggered by activation of oncogenes such as activated Ras. ROS act as second messengers and can influence a variety of cellular process including growth factor responses and cell survival. We have examined the contribution of ROS production to the effects of N-Ras(G12D) and H-Ras(G12V) on normal human CD34(+) progenitor cells. Activated Ras strongly up-regulated the production of both superoxide and hydrogen peroxide through the stimulation of NADPH oxidase (NOX) activity, without affecting the expression of endogenous antioxidants or the production of mitochondrially derived ROS. Activated Ras also promoted both the survival and the growth factor-independent proliferation of CD34(+) cells. Using oxidase inhibitors and antioxidants, we found that excessive ROS production by these cells did not contribute to their enhanced survival; rather, ROS promoted their growth factor-independent proliferation. Although Ras-induced ROS production specifically activated the p38(MAPK) oxidative stress response, this failed to induce expression of the cell-cycle inhibitor, p16(INK4A); instead, ROS promoted the expression of D cyclins. These data are the first to show that excessive ROS production in the context of oncogene activation can promote proliferative responses in normal human hematopoietic progenitor cells.

Citing Articles

Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia.

Tjahjono E, Daneman M, Meika B, Revtovich A, Kirienko N Front Oncol. 2025; 14:1532857.

PMID: 39902131 PMC: 11788353. DOI: 10.3389/fonc.2024.1532857.


Hematopoietic stem cell metabolism within the bone marrow niche - insights and opportunities.

Kemna K, van der Burg M, Lankester A, Giera M Bioessays. 2024; 47(2):e2400154.

PMID: 39506498 PMC: 11755706. DOI: 10.1002/bies.202400154.


Reactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemia.

Khorashad J, Rizzo S, Tonks A Cancer Drug Resist. 2024; 7:5.

PMID: 38434766 PMC: 10905166. DOI: 10.20517/cdr.2023.125.


A mechanistic assessment of the nature of pharmacodynamic drug-drug interaction in vivo and in vitro.

Bisaso K, Mukonzo J, Ette E In Silico Pharmacol. 2023; 11(1):31.

PMID: 37899968 PMC: 10611690. DOI: 10.1007/s40203-023-00168-y.


Plasma-Activated Solutions Mitigates DSS-Induced Colitis via Restoring Redox Homeostasis and Reversing Microbiota Dysbiosis.

Sun T, Ren K, Xu G, Ma R, Wang X, Min T Adv Sci (Weinh). 2023; 10(34):e2304044.

PMID: 37870220 PMC: 10700679. DOI: 10.1002/advs.202304044.